Dutch scientists track COVID drugs in real patients
NCT ID NCT05195060
Summary
This study observed over 1,100 adults in the Netherlands who received new COVID-19 antibody or antiviral treatments. The goal was to see how the virus and the patient's body responded in real-world use, outside of controlled trials. Researchers collected blood and swab samples to track the virus, check for new variants, and monitor safety to learn which patients benefit most.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam University Medical Centre
Amsterdam, North Holland, 1105 AZ, Netherlands
-
Amsterdam University Medical centre - VUMC
Amsterdam, North Holland, 1081 HV, Netherlands
-
Leiden universitair medisch centrum
Leiden, 2333ZA, Netherlands
-
Radboud Universitair Medisch Centrum
Nijmegen, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.